Abrus

Other Names

Abrus abrus (L.) W.WightAbrus cyaneus R.Vig.Abrus maculatus NoronhaAbrus minor Desv.Abrus pauciflorus Desv.Abrus precatoriusAbrus precatorius f. luteoseminalis H.St.JohnAbrus precatorius L.Abrus precatorius var. erythrospermus VoigtAbrus precatorius var. leucospermus VoigtAbrus precatorius var. melanospermus VoigtAbrus precatorius var. novoguineensis Zipp. ex Miq.Abrus squamulosus E.Mey.Abrus tunguensis LimaAdekudeAmabopeAnya nnunuBead treeBead vineBlack-eyed SusanBuddhist rosary beadCessaneCoondrimanyCoral beadCoral bead plantCoral beanCountry licoriceCrab's eyeDa marzayaDeadly crab's eyeDedekuadeGidee gideeGlycine abrus L.GulaganjiGuñjāGunjaHong douIdonzakaraIndian beadIndian licoriceIwere-jejeJamaica wild licoriceJequirityJequirity beanJohn Crow BeadJumbie beadKachencheKundumaniLicorice vineLove beanLove peaLucky beanLucky bean creeperLufiamboLufyamboMantumbiMdelaMienie mienieMini-miniMinnie-minniesMongaluchiMtipitipiMukakenjengeMutitiNdelaNsimaniObirekuaiuraOjuologboOlindaOrobus americanus Mill.Oto-bereberePaternoster peaPaternostertjiesPrayer beadPrayer beanPrecatory beanPrecatory peaRattiRed-bead vineRetteeRosary beanRosary peaSeminole beadUmkhokhaUmphitsiWeather plantWeather vineWild licoriceZaga latifolia Raf.Zaga parvifolia Raf.

Synopsis

Abrus: A Comprehensive Reference Article

1. Identity and Botanical Classification

Taxonomy and Nomenclature

Abrus is a genus of flowering plants in the family Fabaceae (Leguminosae), subfamily Papilionoideae, distributed across tropical and subtropical regions worldwide. The genus Abrus Adans. (Fabaceae) is widely distributed in tropical and subtropical regions and includes four medicinally important species in China with significant therapeutic potential. The most widely studied and medically significant species is Abrus precatorius L., although several other species in the genus carry ethnopharmacological importance.

Abrus precatorius (commonly known as rosary pea or jequirity bean) is a widely distributed leguminous plant traditionally used in Ayurveda, Traditional Chinese Medicine (TCM), and African folk medicine. In India and Ayurvedic texts it is referred to as Gunja or Gunjja; in Hindi it is called Ratti; in English it has also historically been called jequirity, crab's eye, precatory bean, and Indian licorice. Its leaves are served as tea in China, and its roots are employed as a substitute for Glycyrrhiza uralensis or as a raw material for the extraction of glycyrrhizin in India.

Other Medicinally Important Species

Notably, Abrus precatorius L. has been traditionally used to treat headaches, wind-phlegm disorders, and carbuncles. Abrus cantoniensis Hance and Abrus mollis Hance are valued in ethnomedicine as hepatoprotective agents, whereas Abrus pulchellus Wall. ex Thwaites shows confirmed medicinal properties. Abrus cantoniensis Hance, belonging to the genus Abrus of the subfamily Papilionoideae (Leguminous), is an economically valuable medicinal plant in southern China and was officially recorded in the Chinese Pharmacopoeia. As an edible and medicinal plant, it can be used to make soup or herbal tea along with other ingredients and is commonly used as a folk medicinal supplement to prevent hepatitis and other chronic liver diseases.

Botanical Description

Abrus precatorius is a herbaceous flowering plant in the bean family Fabaceae. It is a slender, perennial climber with long, pinnate-leafleted leaves that twines around trees, shrubs, and hedges. The plant is best known for its seeds, which are used as beads and in percussion instruments, and which are toxic because of the presence of abrin. The plant is native to Asia and Australia. It has a tendency to become weedy and invasive where it has been introduced.

The pods are ellipsoid, 2.5–4 cm long, and contain four to six round, glossy, red and black, hard, and dreadfully toxic seeds. Beyond its medicinal relevance, the seeds of A. precatorius are historically notable for their remarkably uniform weight (approximately 0.1 g), which has been traditionally employed as a standard unit of measurement.

Plant Parts Used and Common Preparations

Parts used include roots, seeds, and leaves. The seeds of A. precatorius contain flavonoids, steroids, alkaloids, anthocyanins, lectins, and fixed oils and can treat skin diseases, ulcers, and nervous system disorders. The roots contain glycyrrhizin and alkaloid compounds and are used to treat rheumatism, alexiteric (antidote to poison), sore throat, and vomiting. Beyond their therapeutic applications, Abrus species are valued as nutraceutical resources, traditionally prepared as beverages, teas, or functional soups in dietotherapy.

2. Traditional and Historical Use

Ayurveda and Indian Subcontinent

Abrus precatorius is native to the Indian subcontinent and is used in many ways in the traditional system of Ayurvedic medicine. Ayurveda recommends the administration of A. precatorius in diseases like alopecia, edema, helminths, skin diseases, itching, urinary disorders, and anti-fertility. Plant parts such as leaf extracts are used for leucoderma; the seed containing abrin is used as a purgative and abortive; and the root extract is used against coughs in the Ayurvedic system of medicine.

The plant is used in traditional herbal formulations to treat many ailments, mainly scratches, sores, and wounds caused by dogs, cats, and mice. In addition, it is also used to treat leucoderma, tetanus, and rabies. Its root is used in the Indian Himalayas for ulcer and rheumatic pain. In Hinduism, Abrus precatorius, known as Gunja or rosary beads, carries spiritual significance. It is valued for its medicinal properties and often used in religious practices and rituals.

Traditionally, the seeds were also used for decorative and gold-weighing purposes. The dry seeds are powdered and taken one teaspoonful once a day for 2 days to cure worm infections. Various African and Indian tribes use the powdered seeds as oral contraceptives. They have also been used against chronic eye diseases, and particularly against trachoma.

Traditional Chinese Medicine (TCM)

Abrus precatorius has been utilized as medicine from very ancient times not only on the Indian subcontinent but also in China and other prehistoric cultures. Applications in TCM include treatment of cough, asthma, rheumatism, and toxic swelling, although safety concerns restrict clinical use. A. precatorius seeds have been used for treating emesis in China.

Traditionally, Abrus cantoniensis Hance was believed to have the effect of soothing the liver, clearing heat, and detoxifying, often used to treat diseases of the liver and inflammation. These effects, as recorded in the Chinese Pharmacopoeia, include relieving dampness, treating jaundice, clearing heat, detoxification, soothing the liver, and alleviating pain. In Guangzhou and Guangxi, China, Abrus cantoniensis Hance is known for its liver-protective properties and is commonly used in herbal teas and soups.

African Folk Medicine

Various African tribes use A. precatorius powdered seeds as oral contraceptives. Traditionally in Malaysia, the leaves of Abrus precatorius, a flowering plant that belongs to the legume family Fabaceae, are used to treat various ailments such as coughs, diarrhoea, wound healing, and even as anticancer and antivirus remedy. The leaves are used as folk medicine by local communities in the western region of Ghana to treat diabetes mellitus.

Unani and Historical Western Use

Abrus precatorius L. is a folk medicine with a long-term medicinal history worldwide, which is extensively applied to various ailments, such as bronchitis, jaundice, hepatitis, contraception, tumor, abortion, malaria, etc. The seeds of the jequirity bean have long been known for their medicinal use in Unani and Ayurvedic medicine. The earliest literature on the toxicity of A. precatorius dates back to 1877, when it was reported that a man who took 40 grains of powdered seeds started to suffer from diarrhea and vomiting within 2 hours of administration.

3. Phytochemistry: Key Constituents and Active Compounds

Overview of Chemical Classes

A. precatorius contains diverse bioactive compounds, including alkaloids, flavonoids, triterpenoids, saponins, and the highly toxic lectin abrin. Several compounds have been identified in the leaves of A. precatorius, including abrine, trigonelline, abruslactone A, hemiphloin, abrusoside A, abrusoside B, abrusoside C, abrusoside D, arabinose, galactose, xylose, choline, hypaphorine, precatorine, glycyrrhizin, montanyl alcohol, inositol, D monomethyl ether, and pinitol.

Glycyrrhizin (glycyrrhizic acid), a conjugate of glucuronic acid and glycyrrhetinic acid, is a triterpenoid saponin known to be the major phytochemical in the leaves of A. precatorius. The leaves contain up to 10% glycyrrhizin and other bioactive compounds. Fifty-five phytochemicals have been putatively identified from A. precatorius leaves, primarily polyphenols, triterpenoids, saponins, and alkaloids, including 24 that had not previously been reported from this species' leaves.

Abrin: The Principal Toxic Lectin

Abrin is a plant toxin obtained from Abrus precatorius seeds. It belongs to the type II ribosomal inactivating proteins (RIPs) consisting of two chains — namely, a catalytically active A chain and a sugar-binding B chain — linked by a single disulfide bond. Four isoforms of abrin have been identified: Abrin-a, Abrin-b, Abrin-c, and Abrin-d. Four isotoxins of abrin have been reported with similar amino-acid composition but different cytotoxicity, of which abrin-a is the most potent toxin.

Three toxins — abrin-I, -II, and -III — and two agglutinins, APA-I and APA-II, have been purified from the seeds of Abrus precatorius. The relative molecular weights are: abrin-I, 64,000; abrin-II and abrin-III, 63,000 each; APA-I, 130,000; and APA-II, 128,000.

Abrus Agglutinins

Abrin and agglutinin-I from the seeds of Abrus precatorius are type II ribosome-inactivating proteins that inhibit protein synthesis in eukaryotic cells. The two toxins share a high degree of sequence similarity; however, agglutinin-I is weaker in its activity. Approximately 200–2000-fold higher concentration of agglutinin-I is needed for the same degree of inhibition as abrin.

Flavonoids and Isoflavonoids (Abruquinones)

The isoflavan quinone abruquinone B isolated from the aerial parts inhibited the survival of P. falciparum with an IC₅₀ value of 1.5 µg/mL. The isoflavans abruquinones K, L, and the isoflavan quinones abruquinones A and D isolated from the whole plant inhibited the survival of T. b. rhodesiense. Phytochemical analyses of Abrus species have identified numerous bioactive constituents, including flavonoids, alkaloids, triterpenoid saponins, organic acids, amino acids, and aliphatic compounds.

For Abrus mollis, the flavonoid C-glycosides, including vicenin-2, isoschaftoside, and schaftoside, were identified as the major active components for hepatic protection against nonalcoholic fatty liver disease, hepatitis, and hepatic fibrosis.

Abrusoside Saponins

The abrusoside group (A, B, C, D, and E) comprises a set of triterpenoid saponins isolated primarily from the leaves. Compounds isolated from A. precatorius include abrin-a and -b, abruquinone A, abrusoside E, 7,5-dihydroxy-6,4'-dimethoxy isoflavone 7-O-β-d-galactopyranoside, and triterpenoid saponins. These compounds are noted for their intense sweetness, exceeding that of sucrose.

4. Mechanisms of Action

Ribosome Inactivation by Abrin

Abrin is an AB-type toxin with a 30-kDa A chain — an RNA N-glycosidase — that irreversibly inactivates the 28S rRNA of the mammalian 60S ribosomal subunit. The A-chain's N-glycosidase activity depurinates a specific adenine residue (A4324) in the eukaryotic 28S rRNA. This modification prevents the ribosome from binding elongation factor 2 (EF-2), thereby blocking protein synthesis and ultimately leading to cell death. Abrin's mechanism specifically targets the conserved alpha-sarcin/ricin loop in the 60S subunit of the ribosome.

The toxin abrin is a dimer. Once inside the cell, the A chain prevents protein synthesis by inactivating the 28S RNA of the ribosome. One molecule of abrin will inactivate up to 1,500 ribosomes. A single molecule of the abrin A chain which reaches the cytosol is sufficient to kill the cell.

Apoptosis Induction

Abrin belongs to the type II family of ribosome-inactivating proteins comprising a galactose-binding B chain coupled with a toxic A chain through a single disulfide linkage. Apart from its RNA-N-glycosidase activity, another role that has been ascribed to abrin is the induction of apoptosis. The signal for apoptosis is triggered at a time point later than the inhibition of protein synthesis. This apoptotic pathway induced by abrin is caspase 3-dependent but caspase 8-independent and involves mitochondrial membrane potential damage and reactive oxygen species production. Overexpression of B-cell lymphocytic-leukaemia proto-oncogene 2 was found to block this apoptotic pathway.

Abrin inhibits protein synthesis and triggers apoptosis in cells. Using an active site mutant of abrin A-chain exhibiting 225-fold lower protein synthesis inhibitory activity than the wild-type, it was demonstrated that inhibition of protein synthesis induced by abrin is the major factor triggering unfolded protein response leading to apoptosis.

B-Chain Cell-Binding Mechanism

Abrin has two chains — A and B. The B chain binds to β-D-galactopyranoside moieties on the cell surface and facilitates the entry of the A chain. The A chain has RNA-N-glycosidase activity, causing depurination of adenine in the 28S rRNA. This prevents the binding of elongation factor to the rRNA, resulting in complete inhibition of RNA translation.

Immunomodulatory Activity of Lectins

Native and heat-denatured Abrus agglutinin stimulates the Th1-type immune response by up-regulating IL-2, IFN-γ, and TNF-α production. The selective tumor-targeting nature of Abrus lectins ensures its place as a potential anticancer agent, and both lectins (agglutinin and abrin) inhibit the growth of tumors in experimental animals through apoptosis induction.

Hepatoprotective Mechanisms (Abrus cantoniensis)

Total saponins extracted from Abrus cantoniensis Hance (ACS) may exert hepatoprotective activities via MAPK/NF-κB pathway regulation. Abrus cantoniensis is a Chinese medicinal herb used for the treatment of hepatitis. Total saponins extracted from A. cantoniensis are a compound of triterpenoid saponins, which have protective properties against both chemical and immunological liver injuries.

5. Scientific Evidence by Area of Use

5.1 Antidiabetic Activity

In vitro evidence: A 50% ethanolic leaf extract of A. precatorius was evaluated for its effect on insulin-stimulated glucose uptake and related gene expression in differentiated C2C12 myotubes using rosiglitazone as a positive control. A. precatorius leaf extract significantly increased insulin-stimulated glucose uptake and insulin receptor substrate 1 and Akt substrate of 160 kDa gene expression; however, it had no effect on glucose transporter type 4 gene expression. At 250 µg/mL, the increase in glucose uptake was significantly higher than 1 µM rosiglitazone.

Animal (in vivo) evidence: A methanolic leaf extract (APME) was evaluated for in vivo antihyperglycemic activity in streptozotocin-induced diabetic rats by oral administration of 200 mg/kg body weight for 28 days, alongside in vitro insulinotropic effect using mouse insulinoma beta cells (MIN6-β). In diabetic rats, APME treatment significantly restored body weight (26.39%), blood glucose (32.39%), and insulin levels (73.95%) compared to diabetic control rats. In MIN6-β cells, APME potentiated insulin secretion in a concentration-dependent manner at glucose concentrations of 3–16.7 mM and extract concentrations of 5–500 µg/mL.

One study demonstrated that antidiabetic effect of APLE in experimental diabetes mellitus in rats is mediated through multiple mechanisms, including inverse modulation of insulin and GLP-1 with glucagon, inhibition of α-amylase and α-glucosidase enzymatic activity, free radical scavenging, antioxidant activity, and recovery of necro-apoptosized pancreatic β-cells.

Evidence strength: Pharmacological studies have reported antidiabetic activities; however, most findings are based on in vitro and animal models. No human clinical trials for the antidiabetic activity of Abrus leaf extract have been published as of the reviewed literature. The evidence is preliminary and restricted to preclinical models.

5.2 Antimicrobial Activity

In vitro antibacterial activities of hexane, chloroform, and methanolic crude extracts of Abrus precatorius seeds were tested against ten clinical isolates using the agar well diffusion technique. Extracts were obtained using a Soxhlet extractor. At concentrations ranging from 500 µg/mL to 4 µg/mL, Enterococcus faecalis was the most resistant organism tested. The results substantiate the ethnobotanical use of different parts of Abrus precatorius for the treatment of various bacteria-related diseases. Topical application of Abrus precatorius extracts in ointments may be recommended especially for treating superficial infections caused by Staphylococcus aureus.

Evidence strength: All antimicrobial evidence is in vitro only; no clinical trials in human subjects have been conducted. The evidence is insufficient to establish clinical efficacy.

5.3 Anticancer and Antitumor Activity

Abrin is a type II ribosome-inactivating protein with a catalytic efficiency higher than any other toxin belonging to this class of proteins, but it has not been exploited much for use in targeted therapy. Immunotherapy is fast emerging as one of the leading modes of treatment of cancer, in combination with chemotherapy and radiation. Use of immunotoxins — proteins bearing a cell-surface receptor-specific antibody conjugated to a toxin — enhances the efficacy of cancer treatment.

One of the first reports on nuclear localization of abrin documented the construction of an immunotoxin (mAb F1G4-rABRa-A) that inhibits protein synthesis specifically on cells expressing the gonadotropin releasing hormone receptor, following a distinct pathway of internalization compared to native abrin. Abrus lectin (agglutinin and abrin)-derived peptides showed potent in vitro and in vivo antitumor and immunostimulatory properties, which may be used as a potential source of tumor-targeting therapeutic peptides.

Abrus-derived lectins and other bioactive compounds have yet to be tested in cancer clinical trials. As far as clinical trials are concerned, the clinical trials database mentions a few completed trials-based investigations on ricin against infections including cancer; however, no such data is available on abrin-related clinical trials.

Evidence strength: Anticancer evidence is entirely preclinical — in vitro and animal studies only. Future research to evaluate the anticancer effects of A. precatorius metabolites in synergy is encouraged, as the majority of studies investigated the activities of compounds individually.

5.4 Anti-inflammatory Activity

Modern pharmacological studies have demonstrated that A. precatorius possesses wide-ranging biological activities, including anti-inflammatory activity, among others. Abrus cantoniensis Hance was traditionally believed to have the effect of soothing the liver, clearing heat, and detoxifying; modern pharmacological research indicates that it has liver protection, anti-inflammation, antioxidant, immunomodulation, and anti-tumor effects.

Evidence strength: Pharmacological studies have reported anti-inflammatory activities; however, most findings are based on in vitro and animal models, with limited standardized extraction methods and no established clinical dosage protocols.

5.5 Hepatoprotective Activity (Abrus cantoniensis)

Abrus mollis is commonly used as a traditional Chinese medicine for the treatment of liver diseases due to its hepatoprotection and anti-inflammation. Abrus cantoniensis Hance is an ancient Chinese medicine herb known for its therapeutic effects. Studies investigated its potential protective effect against carbon tetrachloride (CCl4)-induced liver damage in mice. CCl4 was intraperitoneally injected into different mice groups; groups received daily doses of ACH via gavage throughout the study at doses of 25 mg/kg, 50 mg/kg, and 100 mg/kg over 31 days. According to the findings, ACH administration prominently mitigated liver pathological lesions and the increased liver index induced by CCl4 in mice (p < 0.05).

Evidence strength: As an edible and medicinal plant, A. cantoniensis can be used to make soup or herbal tea; the dried whole plant without pods, mainly the roots and stems, exhibits antioxidant, antiviral, immunomodulatory, hepatoprotective, and hypolipidemic effects. Evidence is animal-model based; formal clinical trials in humans have not been published.

5.6 Antiparasitic Activity

An aqueous extract of seeds inhibited the survival of C. elegans (N2, Bristol) with an LC₅₀ value of 15.8 mg/mL. The isoflavan quinone abruquinone B isolated from the aerial parts inhibited the survival of P. falciparum with an IC₅₀ value of 1.5 µg/mL. The isoflavans abruquinones K, L, and the isoflavan quinones abruquinones A and D isolated from the whole plant inhibited the survival of T. b. rhodesiense. In vivo antiplasmodial and anti-trypanosomal studies are warranted.

Evidence strength: Strictly in vitro; no human clinical data exist.

5.7 Anti-serotonergic and Migraine-Related Activity

An ethyl acetate extract of Abrus precatorius leaves demonstrated anti-serotonergic activity on a frog fundus strip, using sumatriptan as a standard. This activity has been proposed as a basis for potential utility in migraine, though this remains speculative and without clinical study.

6. Body Systems and Health Areas Associated with Abrus

A. precatorius shows several therapeutic activities including antimicrobial, anti-helminthic, antimalarial, antifungal, nephroprotective, immunomodulatory, neuromuscular, antidiabetic, anti-inflammatory, antifertility, antiserotonergic, antidiarrheal, antitumor, antispasmodic, and memory-enhancing properties.

Endocrine / Metabolic System: Antidiabetic effects via insulin sensitization and pancreatic β-cell recovery (preclinical).
Hepatic System: Abrus mollis is used for treatment of liver diseases due to hepatoprotection and anti-inflammation; the flavonoid C-glycosides vicenin-2, isoschaftoside, and schaftoside have been identified as the major active components for hepatic protection against nonalcoholic fatty liver disease, hepatitis, and hepatic fibrosis.
Immune System: Abrus agglutinin and abrin provide immunoadjuvant effects, potentiating the systemic immune response.
Dermatological: Leaf extracts traditionally used for leucoderma and skin diseases; seed preparations for trachoma.
Reproductive System: Various African and Indian tribes use the powdered seeds as oral contraceptives.
Gastrointestinal: Used traditionally for anti-diarrheal, antispasmodic, and helminthic purposes.
Respiratory: The leaves and roots are sweetish and traditionally used to cure fever, stomatitis, asthma, and bronchitis.
Neurological: Memory-enhancing and neuroprotective activities reported in preclinical studies.
Oncology (experimental): Abrin-based immunotoxins being investigated in cancer research contexts.

7. Dosage Forms and Dosages Reported in Studies

There are no established human clinical dosage protocols for Abrus as a therapeutic agent. Most findings are based on in vitro and animal models, with limited standardized extraction methods and no established clinical dosage protocols. The following dosages appear in the primary research literature exclusively in preclinical (animal) contexts:

Methanolic leaf extract (antidiabetic, rat model): Oral administration of APME at 200 mg/kg body weight for 28 days was used in streptozotocin-induced diabetic rats.
Alloxan diabetic rat model: Diabetes mellitus was established in adult Sprague-Dawley rats (weighing 120–180 g) by daily sequential injection of nicotinamide (48 mg/kg; ip) and Alloxan (120 mg/kg; ip) over 7 days.
In vitro glucose uptake model: At 250 µg/mL, A. precatorius leaf extract, the increase in glucose uptake was significantly higher than 1 µM rosiglitazone.
Abrus cantoniensis hepatoprotective model (mice): ACH-treated groups received daily doses of ACH via gavage at 25 mg/kg, 50 mg/kg, and 100 mg/kg throughout the study period.
Traditional (folk) dosage (seeds, worm infection): The dry seeds are powdered and taken one teaspoonful once a day for 2 days to cure worm infections. This traditional practice carries severe safety risks given the extreme toxicity of abrin.

Abrin as an experimental immunotoxin (human, historical): Clinical trials showed that the human minimum lethal dose of abrin by intravenous injection is 0.3 µg/kg as an immunotoxin for cancer treatment. The report showed that patients tolerated a dose of 0.3 µg/kg without serious adverse effects. This reflects abrin's investigational use as an immunotoxin component, not as a dietary supplement, and reflects extreme hazard at very small doses.

8. Safety: Toxicology, Hazards, and Regulatory Status

Acute Toxicity of Abrin

The seeds of Abrus precatorius contain the poison abrin. Similar in properties to ricin, this toxin binds to ribosomes causing cessation of protein synthesis and cell death. With an estimated human lethal dose of 0.1–1 µg/kg, it has been the cause of fatalities due to accidental and intentional ingestion. Abrin, with an LD₅₀ of 2.8 µg/kg in mice, is one of the most potent known toxins, approximately 75 times more toxic than ricin.

Ingestion of a single seed, well chewed, can be fatal to both adults and children. If the integrity of the seed shell has been compromised (e.g., by chewing or drilling holes, as is done for beadwork or jewelry), abrin can affect the digestive tract even as digestive enzymes act to break down the toxin.

The intraperitoneal LD₅₀ value of purified abrin for mice was found to be 0.91 µg/kg of body weight. The lethal doses of abrin-a and abrin-b for mice recorded within 48 hours were 10 and 25 micrograms per kg of body weight respectively.

Clinical Presentation of Poisoning

The majority of patients present with gastrointestinal symptoms (72.57%) in the form of loose stools, vomiting, and pain abdomen. Bloody diarrhea was present in 29.4%. Neurological involvement in the form of altered sensorium, tremors, and seizures were present in some patients. Sixteen patients (14%) in one case series did not have any features of toxicity.

The classical feature of Abrus toxicity is bloody diarrhea. Other uncommon features include encephalopathy, arrhythmias, and renal failure due to volume depletion. Children with access to rosary pea jewelry can accidentally ingest the peas, exposing them to the abrin toxin which can lead to life-threatening conditions such as gastrointestinal bleeding, dehydration, seizures, and organ failure.

Physical findings and signs of abrin exposure can occur after a symptom-free (latent) period of a few hours to several days. Abrin (and ricin) may cause severe allergic reactions.

Mortality in Poisoning Cases

In a retrospective study of 112 poisoning patients: Of the 112 patients, six patients expired and the rest recovered. All six patients who died had taken a handful of crushed seeds and developed symptoms within 12 hours; all of them had profuse bloody diarrhea, and autopsy showed congestion of the viscera, especially the lungs and intestines.

One pediatric case demonstrated the danger of seeds used in jewelry: A single case of unintentional abrin poisoning was confirmed by the quantitation of l-abrine biomarker in a previously healthy 22-month-old, 11.5-kg female who presented to the hospital after ingesting approximately 20 rosary peas sold as a "peace bracelet." Her primary manifestations were episodes of forceful emesis, and she was tachycardic (HR = 134 bpm).

No Antidote Available

There are no antidotes available for abrin intoxication. There is no antidote for abrin poisoning. Management, largely supportive, may consist of administering intravenous fluids, anti-emetics, and activated charcoal depending on the time of exposure. Investigations showed that vaccination with abrin toxoid or administration of ascorbate may offer some protection against a subsequent abrin challenge, though these remain experimental.

Bioterrorism Classification

Abrin, a type-II ribosome-inactivating protein from the seed of Abrus precatorius, is classified as a Category B bioterrorism warfare agent. The USA Centers for Disease Control and Prevention (CDC) has classified abrin as a Category B agent. Owing to its extreme toxicity and ease of purification and dissemination, abrin is considered a dreaded bioterror agent.

Seed Coat Protective Barrier

The intact, hard seed coat of A. precatorius seeds provides a partial barrier to abrin absorption. The seeds of A. precatorius are extremely toxic and are frequently ingested as a means of suicide. The seed coat, when unbroken, limits but does not fully prevent abrin absorption upon ingestion. Once the seed is chewed, crushed, or otherwise mechanically disrupted, the full toxin load is released.

Sustainability Concerns

Overharvesting of seeds and roots — the most utilized parts — threatens wild populations and reduces biodiversity. Reports from Asia and Africa suggest that unsustainable harvesting practices, often lacking cultivation protocols, are putting pressure on natural populations.

Toxicity of Other Species

The widespread utilization of Abrus species is constrained by the presence of toxic compounds such as abrin and pulchellin. Whereas A. cantoniensis and A. mollis are used with greater safety in prepared herbal teas and soups in China, precaution is still warranted given overlapping toxin profiles, and formal toxicological characterization of these species in human populations remains limited.

References

Health Conditions

Health conditions that Abrus may help support.

No conditions available.

Body Systems

Body systems that Abrus may help support.

No body systems available.